1. Home
  2. PRGO vs APLS Comparison

PRGO vs APLS Comparison

Compare PRGO & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perrigo Company plc

PRGO

Perrigo Company plc

HOLD

Current Price

$13.15

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Apellis Pharmaceuticals Inc.

APLS

Apellis Pharmaceuticals Inc.

HOLD

Current Price

$25.03

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRGO
APLS
Founded
1887
2009
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.7B
IPO Year
1991
2017

Fundamental Metrics

Financial Performance
Metric
PRGO
APLS
Price
$13.15
$25.03
Analyst Decision
Buy
Buy
Analyst Count
4
19
Target Price
$22.50
$33.11
AVG Volume (30 Days)
3.8M
2.2M
Earning Date
11-05-2025
10-30-2025
Dividend Yield
8.83%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.36
Revenue
$4,281,800,000.00
$1,016,397,000.00
Revenue This Year
N/A
$29.00
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$70.45
Revenue Growth
N/A
42.11
52 Week Low
$12.17
$16.10
52 Week High
$30.93
$35.71

Technical Indicators

Market Signals
Indicator
PRGO
APLS
Relative Strength Index (RSI) 33.32 67.89
Support Level $12.93 $23.54
Resistance Level $13.63 $25.52
Average True Range (ATR) 0.43 0.92
MACD 0.29 0.61
Stochastic Oscillator 44.25 92.36

Price Performance

Historical Comparison
PRGO
APLS

About PRGO Perrigo Company plc

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Share on Social Networks: